FNBT
ELV icon

FineMark National Bank & Trust’s Elevance Health ELV Stock Holding History

FineMark National Bank & Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.5M Sell
44,121
-1,046
-2% -$353K 0.48% 55
2025
Q3 		$14.6M Sell
45,167
-2,164
-5% -$673K 0.48% 57
2025
Q2 		$18.4M Buy
47,331
+14,697
+45% +$5.91M 0.63% 38
2025
Q1 		$14.2M Buy
32,634
+481
+1% +$193K 0.52% 59
2024
Q4 		$11.9M Sell
32,153
-661
-2% -$277K 0.41% 68
2024
Q3 		$17.1M Sell
32,814
-150
-0.5% -$80.1K 0.59% 47
2024
Q2 		$17.9M Buy
32,964
+318
+1% +$168K 0.66% 36
2024
Q1 		$16.9M Buy
32,646
+503
+2% +$250K 0.63% 39
2023
Q4 		$15.2M Sell
32,143
-192
-0.6% -$88.8K 0.62% 37
2023
Q3 		$14.1M Sell
32,335
-565
-2% -$256K 0.61% 38
2023
Q2 		$14.6M Sell
32,900
-261
-0.8% -$120K 0.6% 43
2023
Q1 		$15.2M Sell
33,161
-36
-0.1% -$17.1K 0.65% 37
2022
Q4 		$17M Buy
33,197
+65
+0.2% +$33K 0.77% 32
2022
Q3 		$15.1M Sell
33,132
-856
-3% -$410K 0.72% 28
2022
Q2 		$16.4M Buy
33,988
+152
+0.4% +$75.2K 0.73% 30
2022
Q1 		$16.6M Sell
33,836
-150
-0.4% -$68.6K 0.66% 34
2021
Q4 		$15.8M Buy
33,986
+156
+0.5% +$65.6K 0.6% 37
2021
Q3 		$12.6M Buy
33,830
+226
+0.7% +$85.9K 0.53% 46
2021
Q2 		$12.8M Buy
33,604
+384
+1% +$147K 0.52% 45
2021
Q1 		$11.9M Buy
33,220
+1,400
+4% +$450K 0.5% 45
2020
Q4 		$10.2M Sell
31,820
-1,326
-4% -$407K 0.46% 49
2020
Q3 		$8.9M Buy
33,146
+393
+1% +$106K 0.43% 55
2020
Q2 		$8.61M Sell
32,753
-141
-0.4% -$37.6K 0.48% 49
2020
Q1 		$7.47M Buy
32,894
+2,130
+7% +$580K 0.47% 54
2019
Q4 		$9.29M Buy
30,764
+1,211
+4% +$333K 0.46% 58
2019
Q3 		$7.1M Buy
29,553
+41
+0.1% +$11.2K 0.38% 68
2019
Q2 		$8.33M Buy
29,512
+1,789
+6% +$489K 0.46% 55
2019
Q1 		$7.96M Buy
27,723
+504
+2% +$146K 0.46% 53
2018
Q4 		$7.15M Buy
27,219
+1,108
+4% +$305K 0.48% 54
2018
Q3 		$7.16M Sell
26,111
-262
-1% -$68K 0.44% 56
2018
Q2 		$6.28M Buy
26,373
+23,213
+735% +$5.38M 0.38% 64
2018
Q1 		$694K Buy
3,160
+227
+8% +$53.3K 0.04% 207
2017
Q4 		$660K Buy
2,933
+225
+8% +$47.9K 0.04% 203
2017
Q3 		$514K Buy
2,708
+148
+6% +$28.2K 0.03% 228
2017
Q2 		$482K Sell
2,560
-12
-0.5% -$2.16K 0.03% 227
2017
Q1 		$425K Buy
2,572
+750
+41% +$119K 0.03% 240
2016
Q4 		$262K Buy
1,822
+135
+8% +$18.1K 0.02% 297
2016
Q3 		$212K Buy
1,687
+82
+5% +$10.6K 0.02% 319
2016
Q2 		$212K Buy
1,605
+417
+35% +$57.1K 0.02% 302
2016
Q1 		$165K Sell
1,188
-913
-43% -$122K 0.02% 332
2015
Q4 		$292K Sell
2,101
-2,262
-52% -$312K 0.03% 260
2015
Q3 		$611K Sell
4,363
-315
-7% -$47.3K 0.08% 181
2015
Q2 		$768K Sell
4,678
-495
-10% -$79.1K 0.1% 172
2015
Q1 		$798K Buy
5,173
+2
+0% +$285 0.11% 166
2014
Q4 		$650K Sell
5,171
-177
-3% -$21.9K 0.1% 178
2014
Q3 		$639K Buy
5,348
+468
+10% +$53.7K 0.1% 171
2014
Q2 		$525K Buy
4,880
+300
+7% +$30.9K 0.09% 190
2014
Q1 		$456K Buy
4,580
+594
+15% +$53.7K 0.09% 188
2013
Q4 		$369K Buy
3,986
+23
+0.6% +$2.04K 0.08% 214
2013
Q3 		$331K Buy
3,963
+35
+0.9% +$3K 0.08% 213
2013
Q2 		$321K Buy
+3,928
New +$294K 0.1% 191

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

FineMark National Bank & Trust's ELV Position: Q4 2025 in Review

FineMark National Bank & Trust reduced its Elevance Health (ELV) stake by 2.3% in Q4 2025, selling an estimated $353K and leaving 44,121 shares worth $15.5M. The position accounts for 0.48% of the portfolio, ranked #55.

FineMark National Bank & Trust first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.4M in Q2 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • FineMark National Bank & Trust held 44,121 shares of Elevance Health worth $15.5M as of Q4 2025.
  • FineMark National Bank & Trust sold 1,046 Elevance Health shares in Q4 2025, an estimated $353K.
  • Elevance Health made up 0.48% of FineMark National Bank & Trust's portfolio in Q4 2025, its #55 holding.
  • FineMark National Bank & Trust first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • FineMark National Bank & Trust's Elevance Health position peaked at $18.4M in Q2 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.